Pyc Therapeutics Ltd has released a press release.
CEO and CSO Appointments
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Operational Update March Quarter
- Response to ASX Price Query
- Genentech extends research collaboration period
- NHMRC Grant Awarded to Collaborators
- AGM Presentation to Shareholders
Later from PYC Therapeutics
- Operational Update June quarter
- Response to ASX Query
- Appendix 4E - Preliminary Final Report 30 June 2017
- New Delivery Vehicles Show Improved Performance Inside Cells
- PYC Granted US Patent for Peptides Entering Brain Cells
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics